4.6 Article

Deciphering the molecular mechanism of stop codon readthrough

Journal

BIOLOGICAL REVIEWS
Volume 96, Issue 1, Pages 310-329

Publisher

WILEY
DOI: 10.1111/brv.12657

Keywords

stop codon readthrough; mechanism; translation termination; premature termination codon; readthrough activators; molecules; screening

Categories

Funding

  1. Region Hauts-de-France
  2. l'Universite de Lille
  3. Vaincre la mucoviscidose
  4. La Ligue Contre le Cancer
  5. GIP Canceropole Nord Ouest

Ask authors/readers for more resources

Recognition of the stop codon is crucial for terminating translation and synthesizing the correct size protein. Stop codon readthrough can occur under specific conditions, leading to different protein isoforms, and has potential therapeutic implications for genetic diseases caused by nonsense mutations.
Recognition of the stop codon by the translation machinery is essential to terminating translation at the right position and to synthesizing a protein of the correct size. Under certain conditions, the stop codon can be recognized as a coding codon promoting translation, which then terminates at a later stop codon. This event, called stop codon readthrough, occurs either by error, due to a dedicated regulatory environment leading to generation of different protein isoforms, or through the action of a readthrough compound. This review focuses on the mechanisms of stop codon readthrough, the nucleotide and protein environments that facilitate or inhibit it, and the therapeutic interest of stop codon readthrough in the treatment of genetic diseases caused by nonsense mutations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Caspases shutdown nonsense-mediated mRNA decay during apoptosis

J. Jia, A. Furlan, S. Gonzalez-Hilarion, C. Leroy, D. C. Gruenert, D. Tulasne, F. Lejeune

CELL DEATH AND DIFFERENTIATION (2015)

Article Cell Biology

Premature termination codon readthrough in human cells occurs in novel cytoplasmic foci and requires UPF proteins

Jieshuang Jia, Elisabeth Werkmeister, Sara Gonzalez-Hilarion, Catherine Leroy, Dieter C. Gruenert, Frank Lafont, David Tulasne, Fabrice Lejeune

JOURNAL OF CELL SCIENCE (2017)

Article Multidisciplinary Sciences

Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases

Hana Benhabiles, Sara Gonzalez-Hilarion, Severine Amand, Christine Bailly, Anne Prevotat, Philippe Reix, Dominique Hubert, Eric Adriaenssens, Sylvie Rebuffat, David Tulasne, Fabrice Lejeune

PLOS ONE (2017)

Article Cell Biology

Human RBMY regulates germline-specific splicing events by modulating the function of the serine/arginine-rich proteins 9G8 and Tra2-beta

Natacha Dreumont, Cyril F. Bourgeois, Fabrice Lejeune, Yilei Liu, Ingrid E. Ehrmann, David J. Elliott, James Stevenin

JOURNAL OF CELL SCIENCE (2010)

Article Genetics & Heredity

Rescue of nonsense mutations by amlexanox in human cells

Sara Gonzalez-Hilarion, Terence Beghyn, Jieshuang Jia, Nadege Debreuck, Gonzague Berte, Kamel Mamchaoui, Vincent Mouly, Dieter C. Gruenert, Benoit Deprez, Fabrice Lejeune

ORPHANET JOURNAL OF RARE DISEASES (2012)

Article Multidisciplinary Sciences

Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation

Sebastien Apcher, Chrysoula Daskalogianni, Fabrice Lejeune, Benedicte Manoury, Gabriela Imhoos, Lea Heslop, Robin Fahraeus

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Oncology

Targeting nonsense-mediated mRNA decay in colorectal cancers with microsatellite instability

Adem Bokhari, Vincent Jonchere, Anais Lagrange, Romane Bertrand, Magali Syrcek, Laetitia Marisa, Olivier Buhard, Malorie Greene, Anastasia Demidova, Jieshuang Jia, Eric Adriaenssens, Thierry Chassat, Denis S. Biard, Jean-Francois Flejou, Fabrice Lejeune, Alex Duval, Ada Collura

ONCOGENESIS (2018)

Article Multidisciplinary Sciences

2,6-Diaminopurine as a highly potent corrector of UGA nonsense mutations

Carole Trzaska, Severine Amand, Christine Bailly, Catherine Leroy, Virginie Marchand, Evelyne Duvernois-Berthet, Jean-Michel Saliou, Hana Benhabiles, Elisabeth Werkmeister, Thierry Chassat, Romain Guilbert, David Hannebique, Anthony Mouray, Marie-Christine Copin, Pierre-Arthur Moreau, Eric Adriaenssens, Andreas Kulozik, Eric Westhof, David Tulasne, Yuri Motorin, Sylvie Rebuffat, Fabrice Lejeune

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

A role for AKT1 in nonsense-mediated mRNA decay

Martine Palma, Catherine Leroy, Sophie Salome-Desnoulez, Elisabeth Werkmeister, Rebekah Kong, Marc Mongy, Herve Le Hir, Fabrice Lejeune

Summary: Nonsense-mediated mRNA decay (NMD) is a highly regulated quality control mechanism that degrades mRNAs containing premature termination codons. AKT1 kinase plays a crucial role in NMD by phosphorylating UPF1, which may have implications in cancer processes and therapy due to its overactivation in cancer cells.

NUCLEIC ACIDS RESEARCH (2021)

Article Biochemistry & Molecular Biology

Nonsense-Mediated mRNA Decay, a Finely Regulated Mechanism

Fabrice Lejeune

Summary: Nonsense-mediated mRNA decay (NMD) is a mechanism for rapidly eliminating mRNAs with premature termination codons and also regulates multiple genes. Researchers have discovered that NMD must be regulated to express genes that are normally repressed by NMD under specific physiological conditions, so a comprehensive understanding of NMD regulation is important for therapeutic purposes.

BIOMEDICINES (2022)

Article Biotechnology & Applied Microbiology

Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis

Catherine Leroy, Sacha Spelier, Nadege Charlene Essonghe, Virginie Poix, Rebekah Kong, Patrick Gizzi, Claire Bourban, Severine Amand, Christine Bailly, Romain Guilbert, David Hannebique, Philippe Persoons, Gwenaelle Arhant, Anne Prevotat, Philippe Reix, Dominique Hubert, Michele Gerardin, Mathias Chamaillard, Natalia Prevarskaya, Sylvie Rebuffat, George Shapovalov, Jeffrey Beekman, Fabrice Lejeune

Summary: DAP can correct nonsense mutations in genetic diseases, restore gene function, and has therapeutic potential.

MOLECULAR THERAPY (2023)

Article Biochemistry & Molecular Biology

Identifying Potent Nonsense-Mediated mRNA Decay Inhibitors with a Novel Screening System

Julie Carrard, Fiona Ratajczak, Josephine Elsens, Catherine Leroy, Rebekah Kong, Lucie Geoffroy, Arnaud Comte, Guy Fournet, Benoit Joseph, Xiubin Li, Sylvie Moebs-Sanchez, Fabrice Lejeune

Summary: The study has built a new screening system and identified two new molecules that can effectively inhibit nonsense-mediated mRNA decay (NMD). These molecules show no cellular toxicity at tested concentrations and have been validated in a lung cancer model with a nonsense mutation.

BIOMEDICINES (2023)

Review Biochemistry & Molecular Biology

Nonsense-mediated mRNA decay at the crossroads of many cellular pathways

Fabrice Lejeune

BMB REPORTS (2017)

No Data Available